ASLN - Aslan Pharmaceuticals to Present at the 2nd Annual H.C. Wainwright Autoimmune and Inflammatory Disease Virtual Conference: Skin Diseases Conditions and Disorders | Benzinga
SAN MATEO, Calif. and SINGAPORE, March 27, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceutical (NASDAQ:ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that management will give a virtual company presentation at the 2nd Annual H.C. Wainwright Autoimmune and Inflammatory Disease Virtual Conference: Skin Diseases, Conditions and Disorders, to be held virtually on Thursday, March 28, 2024. ASLAN management will also be available for one-on-one meetings with investors on the day of the conference. Please register for the event via this link or contact your representative at H.C. Wainright to schedule a meeting.
Company Presentation Information
Format: Virtual presentation
Presenter: Carl Firth, CEO, ASLAN Pharmaceuticals
Date: Thursday, March 28, 2024
Time: 8:00 a.m. EDT
Institutional investors and industry participants are invited to register to listen to the presentation via this link. A copy of the presentation will be posted to the Investor Relations section of ...